Jonas99

CDXC 4.8: Small Float Biotech backed by Li Ka Shing

Giá lên
NASDAQ:CDXC   ChromaDex Corporation
In this market where SPEC trades at billions with NO revenue, I like CDXC though I may be early. Yes it's not TSLA, yes Value does not work in this market but

With a tiny market cap of 290 mil and revenue growth at 40% (still early-stage market), I am betting with Li Ka Shing, one of the richest and other top 20 institutions including Blackrock who collectively owns 55% of the stock. Short interest is small at 7%.

The better story is that the stock has been basing for a long time, and technicals are improving. I don't want to wait for breakout then buy as by then I would be paying too much a premium. So good enough for me with the IMPROVING technicals and a largely positive trend, and a real growth story.

investors.chromadex....n-China/default.aspx

asia.nikkei.com/Busi...-scientific-research

Top Shareholders
Top 25 shareholders own 54.62% of the company
Ownership Name Shares Current Value Change % Portfolio %
10.49%
Ka-shing Li 6,500,937 $31.4m 0% no data
10.29%
Hoi Shuen Chau 6,377,783 $30.8m 0% no data
4.53%
BlackRock, Inc. 2,804,544 $13.5m -0.81% no data
3.97%
The Vanguard Group, Inc. 2,461,485 $11.9m 9.03% no data
3.8%
Li Ka Shing (Global) Foundation, Endowment Arm 2,353,139 $11.4m 0% 3.25%
3.11%
Phillip and Patricia Frost Philanthropic Foundation, Inc, Endowment Arm 1,929,542 $9.3m 0% 42.91%
2.76%

Thông báo miễn trừ trách nhiệm

Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.